Free Trial
The Market Does Not Wait. MarketBeat All Access for Just $149
Get the Deal
Claim MarketBeat All Access Sale Promotion

This company has been marked as potentially delisted and may not be actively trading.

MEI Pharma (MEIP) Short Interest Ratio & Short Volume

MEI Pharma logo
Compare

MEI Pharma Short Interest Overview

As of August 31, 2025, MEI Pharma (MEIP) had a short interest of 2.64 million shares sold short, representing 8.71% of the public float. This marks a 7.32% increase in short interest since the prior report. The short interest ratio (days to cover) is 1.9, meaning it would take 1.9 days of the average trading volume of 919,067 shares to cover all short positions.

Current Short Interest
2,640,000 shares
Previous Short Interest
2,460,000 shares
Change Vs. Previous Month
7.32%
Dollar Volume Sold Short
$12.83 million
Short Interest Ratio
1.9 Days to Cover
Last Record Date
August 31, 2025
Outstanding Shares
32,838,000 shares
Float Size
30,310,000 shares
Short Percent of Float
8.71%
Today's Trading Volume
3,979,920 shares
Average Trading Volume
919,067 shares
Today's Volume Vs. Average
433%
Short Selling MEI Pharma?
A Guide To High-Short-Interest Stocks

Sign up to receive the latest short interest report for MEI Pharma and its competitors with MarketBeat's FREE newsletter.

Get Report
SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.
Skip Charts & View Short Interest History
Short Interest ChartDays to Cover ChartShort Percent of Float Chart

MEIP Short Interest Over Time

MEIP Days to Cover Over Time

MEIP Percentage of Float Shorted Over Time

MEI Pharma Tesla Short Interest History & Recent Changes

Export
Report DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date
8/31/20252,640,000 shares $12.83 million +7.3%8.7%1.9 $4.86
8/15/20252,460,000 shares $12.03 million +14.4%40.0%2.3 $4.89
7/31/20252,150,000 shares $11.07 million +12,046.9%34.2%2.2 $5.15
7/15/202517,700 shares $54.34 thousand +254.0%0.3%0 $3.07
6/30/20255,000 shares $12.35 thousand +284.6%0.1%0.4 $2.47
6/15/20251,300 shares $2.98 thousand -51.9%0.0%0.2 $2.29
5/31/20252,700 shares $6.02 thousand +42.1%0.0%0.3 $2.23
5/15/20251,900 shares $4.05 thousand No Change0.0%0.2 $2.13
4/30/20251,900 shares $3.88 thousand -59.6%0.0%0.2 $2.04
4/15/20254,700 shares $9.59 thousand +80.8%0.1%0.5 $2.04
3/31/20252,600 shares $5.69 thousand -25.7%0.0%0.3 $2.19
3/15/20253,500 shares $8.16 thousand -39.7%0.1%0.2 $2.33
2/28/20255,800 shares $14.85 thousand +38.1%0.1%0.3 $2.56
2/15/20254,200 shares $11.30 thousand -27.6%0.1%0.2 $2.69
1/31/20255,800 shares $16.53 thousand -39.0%0.1%0.3 $2.85
1/15/20259,500 shares $26.32 thousand -27.5%0.1%0.2 $2.77
12/31/202413,100 shares $32.23 thousand -60.5%0.2%0.3 $2.46
12/15/202433,200 shares $89.64 thousand -32.1%0.5%0.7 $2.70
11/30/202448,900 shares $137.90 thousand -23.0%0.7%1.1 $2.82
11/15/202463,500 shares $185.42 thousand -21.6%1.0%1.5 $2.92
10/31/202481,000 shares $251.10 thousand +504.5%1.2%1.9 $3.10
10/15/202413,400 shares $36.31 thousand -30.9%0.2%0.7 $2.71
9/30/202419,400 shares $55.29 thousand +19.0%0.3%0.2 $2.85
9/15/202416,300 shares $49.39 thousand +45.5%0.3%0.2 $3.03
8/31/202411,200 shares $34.72 thousand -30.4%0.2%0.1 $3.10
8/15/202416,100 shares $51.04 thousand -66.9%0.3%0.2 $3.17
7/31/202448,600 shares $180.31 thousand +636.4%0.8%0.5 $3.71
7/15/20246,600 shares $18.78 thousand -62.7%0.1%0.1 $2.85
6/30/202417,700 shares $51.51 thousand +22.1%0.3%1 $2.91
6/15/202414,500 shares $42.05 thousand +7.4%0.2%0.8 $2.90
5/31/202413,500 shares $38.61 thousand -55.7%0.2%0.6 $2.86
5/15/202430,500 shares $94.70 thousand +33.8%0.5%1.5 $3.11
4/30/202422,800 shares $69.54 thousand +9.1%0.4%1.1 $3.05
4/15/202420,900 shares $67.93 thousand +168.0%0.3%1 $3.25
3/31/20247,800 shares $31.20 thousand -14.3%0.1%0.3 $4.00
3/15/20249,100 shares $34.85 thousand -27.2%0.2%0.4 $3.83
2/29/202412,500 shares $51.88 thousand +23.8%0.2%0.4 $4.15
2/15/202410,100 shares $46.16 thousand -97.0%0.2%0.3 $4.57
1/31/2024331,500 shares $1.49 million -1.1%5.4%7 $4.50
1/15/2024335,200 shares $1.94 million -0.7%5.5%6.7 $5.80
SpaceX will mint billionaires. You won't be one of them. (Ad)

By the time a company goes public, 95% of profits have already been made. Insiders bought SpaceX at $20 billion - you'd be buying at $1.75 trillion. But one small, publicly traded company sits directly in SpaceX's path, still priced like Wall Street hasn't noticed. It powers the infrastructure Musk's operation can't run without. Dylan Jovine is naming the ticker free - before the June S-1 closes the window.tc pixel

Get the ticker now before the June S-1 closes the window
12/31/2023337,500 shares $1.96 million -7.5%5.5%6.9 $5.80
12/15/2023365,000 shares $2.31 million -5.7%5.9%7.1 $6.33
11/30/2023386,900 shares $2.38 million -2.8%6.3%6.6 $6.14
11/15/2023398,100 shares $3.12 million -25.7%6.5%7.4 $7.84
10/31/2023536,100 shares $3.66 million +7.4%8.9%13 $6.82
10/15/2023499,000 shares $3.34 million +18.8%8.2%12.4 $6.70
9/30/2023419,900 shares $2.94 million +57.3%6.9%9.1 $7.01
9/15/2023267,000 shares $1.38 million +3.6%4.4%6.1 $5.18
8/31/2023257,700 shares $1.37 million -29.8%4.3%7 $5.32
8/15/2023367,300 shares $2.57 million +16.0%6.1%7.9 $7.00
7/31/2023316,700 shares $2.24 million +1.1%5.2%5.7 $7.07
7/15/2023313,200 shares $2.33 million -4.7%5.2%4.8 $7.44
6/30/2023328,700 shares $2.16 million +2.3%5.4%5.1 $6.58
6/15/2023321,300 shares $2.37 million +5.6%5.3%4.8 $7.38
5/31/2023304,400 shares $2.34 million +28.4%5.0%4.2 $7.70
5/15/2023237,100 shares $1.69 million -14.7%3.9%2.9 $7.11
4/30/2023277,900 shares $1.41 million +17.7%4.6%3.8 $5.09
4/15/2023236,100 shares $1.13 million -95.6%3.9%3.9 $4.80
3/31/20235,340,000 shares $1.22 million +1.3%N/A5 $0.23
3/15/20235,270,000 shares $1.32 million +20.9%N/A4.7 $0.25
2/28/20234,360,000 shares $968.79 thousand +0.9%N/A3 $0.22
2/15/20234,320,000 shares $1.31 million +24.1%N/A3.2 $0.30
1/31/20233,480,000 shares $992.50 thousand -23.7%N/A2.8 $0.29
1/15/20234,560,000 shares $1.49 million +19.4%N/A3.6 $0.33
12/30/20223,820,000 shares $930.55 thousand +11.7%N/A3 $0.24
12/15/20223,420,000 shares $837.90 thousand -25.3%N/A2.7 $0.25
11/30/20224,580,000 shares $1.56 million +4.8%N/A3.9 $0.34
11/15/20224,370,000 shares $1.51 million -13.3%N/A5.9 $0.34
10/31/20225,040,000 shares $1.71 million +2.7%N/A6.8 $0.34
10/15/20224,910,000 shares $1.85 million +4.9%N/A6.1 $0.38
9/30/20224,680,000 shares $1.81 million +0.7%N/A5.1 $0.39
9/15/20224,650,000 shares $2.32 million -0.6%N/A2.9 $0.50
8/31/20224,680,000 shares $2.37 million -7.9%N/A2.1 $0.51
8/15/20225,080,000 shares $2.94 million -9.1%N/A1.6 $0.58
7/31/20225,590,000 shares $2.71 million -3.6%N/A1.6 $0.48
7/15/20225,800,000 shares $3.31 million -19.1%N/A1.3 $0.57
6/30/20227,170,000 shares $4.34 million -21.4%N/A1.3 $0.61
6/15/20229,120,000 shares $4.50 million -12.6%15.5%1.2 $0.49
5/31/202210,430,000 shares $4.96 million No ChangeN/A1.5 $0.48
5/15/202210,430,000 shares $5.40 million -3.9%N/A1.8 $0.52
4/30/202210,850,000 shares $5.34 million +23.0%10.0%1.9 $0.49
4/15/20228,820,000 shares $5.01 million +33.2%8.1%1.7 $0.57
3/31/20226,620,000 shares $3.99 million -10.3%6.1%1.9 $0.60
3/15/20227,380,000 shares $12.55 million +1.0%6.8%7.7 $1.70
2/28/20227,310,000 shares $15.79 million +10.8%6.7%6.8 $2.16
2/15/20226,600,000 shares $14.26 million +1.1%6.1%3.7 $2.16
1/31/20226,530,000 shares $12.60 million -8.5%6.0%3.9 $1.93
1/15/20227,140,000 shares $17.78 million +8.0%6.4%4.7 $2.49
12/31/20216,610,000 shares $17.65 million -5.4%6.2%4.5 $2.67
12/15/20216,990,000 shares $16.99 million -20.1%6.5%4.8 $2.43
SpaceX eyes a 1.75 trillion valuation - here's what to know (Ad)

Elon Musk's team has quietly filed confidential paperwork with the SEC for what Bloomberg estimates could be a $1.75 trillion IPO - larger than Saudi Aramco and any tech offering in history. CNBC calls it 'the big market event of 2026.' According to former tech executive and angel investor Jeff Brown, there's a way to claim a stake before the public filing drops, starting with as little as $500.tc pixel

See how to get positioned in SpaceX before the announcement goes public
11/30/20218,750,000 shares $29.49 million -1.8%8.3%6.9 $3.37
11/15/20218,910,000 shares $27.89 million +1.0%9.8%18.7 $3.13
10/29/20218,820,000 shares $24.87 million -1.5%8.5%20.6 $2.82
10/15/20218,950,000 shares $26.04 million -2.4%8.7%20.4 $2.91
9/30/20219,170,000 shares $25.31 million -4.5%8.9%21.4 $2.76
9/15/20219,600,000 shares $26.11 million +0.3%9.3%22.6 $2.72
8/31/20219,570,000 shares $26.80 million +0.2%9.3%21 $2.80
8/13/20219,550,000 shares $26.26 million +5.3%9.2%21 $2.75
7/30/20219,070,000 shares $24.49 million -5.0%8.8%16.3 $2.70
7/15/20219,550,000 shares $25.21 million -1.6%9.5%16.8 $2.64
6/30/20219,700,000 shares $27.65 million -15.1%9.6%16.3 $2.85
6/15/202111,420,000 shares $35.29 million +3.3%11.3%18.2 $3.09
5/28/202111,060,000 shares $31.85 million -1.3%11.0%17.3 $2.88

MEIP Short Interest - Frequently Asked Questions

Short interest is the volume of MEI Pharma shares that have been sold short but have not yet been closed out or covered. As of August 31st, traders have sold 2,640,000 shares of MEIP short. 8.71% of MEI Pharma's shares are currently sold short. Learn More on MEI Pharma's current short interest.

The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. MEIP shares currently have a short interest ratio of 1.9. Learn More on MEI Pharma's short interest ratio.

Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 8.71% of MEI Pharma's floating shares are currently sold short.

MEI Pharma saw a increase in short interest in August. As of August 31st, there was short interest totaling 2,640,000 shares, an increase of 7.3% from the previous total of 2,460,000 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment.

MEI Pharma currently has issued a total of 32,838,000 shares. Some of MEI Pharma's outstanding shares are available for trading, while others are subject to various restrictions. The public float, also referred to as floating shares or "the float", are shares that publicly owned, unrestricted and available to trade on the open market. MEI Pharma currently has a public float of 30,310,000 shares.

8.71% of MEI Pharma's shares are currently sold short. Here is how the short interest of companies in the industry of "pharmaceutical products" compare to MEI Pharma: Evolus, Inc. (10.64%), Benitec Biopharma Limited (7.09%), Century Therapeutics, Inc. (6.98%), Altimmune, Inc. (27.69%), Cellectis S.A. (0.43%), Rocket Pharmaceuticals, Inc. (25.09%), SNDL Inc. (0.82%), Ovid Therapeutics (7.44%), Opus Genetics, Inc. (3.17%), Puma Biotechnology, Inc. (10.37%),

As of the most recent reporting period, the following stocks had the largest short interest positions: SPDR S&P 500 ETF Trust ($73.23 billion), Invesco QQQ ($29.52 billion), iShares Russell 2000 ETF ($20.82 billion), iShares 20+ Year Treasury Bond ETF ($10.76 billion), Palo Alto Networks, Inc. ($9.37 billion), Strategy Inc ($7.58 billion), Invesco S&P 500 Equal Weight ETF ($6.78 billion), SPDR S&P Biotech ETF ($6.72 billion), AppLovin Corporation ($6.37 billion), and iShares iBoxx $ Investment Grade Corporate Bond ETF ($6.29 billion). View all of the most shorted stocks.

Short selling MEIP is an investing strategy that aims to generate trading profit from MEI Pharma as its price is falling. MEIP shares are trading up $0.41 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit.

A short squeeze for MEI Pharma occurs when it has a large amount of short interest and its stock increases in price. This forces short sellers to cover their short interest positions by buying actual shares of MEIP, which in turn drives the price of the stock up even further.

Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including MEIP, twice per month. The most recent reporting period available is August, 31 2025.

Understanding short interest metrics can help you assess how traders are positioning around a stock like MEIP:

  • Shares Sold Short: The total number of shares that have been sold by short sellers but have not yet been covered or closed out. A high number may indicate bearish sentiment.
  • Short Float: The percentage of a company’s publicly available shares (or "float") that are sold short. A higher short float suggests a greater portion of the stock is being bet against.
  • Days to Cover (Short Interest Ratio): This estimates how many days it would take short sellers to cover their positions, based on average daily trading volume. Higher values can signal potential for a short squeeze if buying pressure increases.

These metrics are often used by traders to gauge sentiment, volatility risk, and the potential for price movements based on short covering activity.


Related Companies
Short Interest Tools

This page (NASDAQ:MEIP) was last updated on 5/22/2026 by MarketBeat.com Staff.
From Our Partners
To Avoid 67 Million Blackouts, Trump Signs Emergency Backing of New Energy Tech
President Trump has used emergency executive powers to back a new energy technology described as 326 times mor...
Altimetry | Sponsoredtc pixel
The SpaceX supplier that shipped 5 billion chips to Starlink
When Nvidia surged 770%, its data center cooling supplier Vertiv climbed 1,700%. When Apple ran 2,000%, suppli...
Weiss Ratings | Sponsoredtc pixel
This stock has 30 days of quiet left
A small power equipment company with $1.5 billion in orders is flying under the radar - but not for long. When...
Behind the Markets | Sponsoredtc pixel
Elon’s Biggest Launch Ever: 15x Bigger Than SpaceX
The Man Who Called Nvidia Before It Soared 1,000% Issues New Elon Musk BUY Alert Luke Lango was ranked Amer...
InvestorPlace | Sponsoredtc pixel
"Computers are about to become obsolete" - George Gilder. Here’s why.
George Gilder predicted the iPhone 16 years early, called Netflix a decade before it dominated streaming, and ...
Eagle Publishing | Sponsoredtc pixel
Your $29.97 book is free today
Why Some Traders Skip Stocks Entirely You don't need a big account to trade options. In fact, options ca...
Profits Run | Sponsoredtc pixel
Maybe the Greatest Strategy of the Decade
Nate Bear, Lead Technical Tactician at Monument Traders Alliance, is going public with his highest-conviction ...
Monument Traders Alliance | Sponsoredtc pixel
A letter from Shannon Stansberry
Porter Stansberry nearly canceled the entire project. When he first saw the claimed returns - only one down ye...
Porter & Company | Sponsoredtc pixel